Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

New cancer treatments aim to reduce side effects and improve effectiveness.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

Deucravacitinib helped a man regrow hair significantly.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

2% Minoxidil does not prevent hair loss during chemotherapy.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

The tool accurately tracks eyebrow hair loss in chemotherapy patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

The committee decided not to approve the drug due to low effectiveness and high risks.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.